Response by Golwala et al to Letter Regarding Article, "Implantable Cardioverter-Defibrillator for Nonischemic Cardiomyopathy: An Updated Meta-Analysis"
Circulation. 2017 Jun 20;135(25):e1200-e1202.
doi: 10.1161/CIRCULATIONAHA.117.028200.
1 From Brigham and Women's Heart and Vascular Institute, Boston, MA (H.G., N.S.B.); Division of Cardiovascular Diseases, University of Alabama, Birmingham (N.S.B., G.A., P.A.); and Section of Cardiology, Birmingham Veterans Affairs Medical Center, AL (P.A.).